HEARO
LIVE

Serial Number

88876444

Owner

HEARO TECHNOLOGIES, LLC

Attorney

James Barta

First Use Date

Jan 1, 2019

Filing Date

Apr 17, 2020

Add to watchlist:

No watchlists yet
View on USPTO

HEARO Trademark

Serial Number: 88876444 • Registration: 6414311

HEARO is a trademark filed by HEARO TECHNOLOGIES, LLC on April 17, 2020. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

HEARO TECHNOLOGIES, LLC (3 trademarks)

301 NORTH ADAMS AVENUE
LEBANON, MO 65536

Entity Type: 16

Trademark Details

Filing Date

April 17, 2020

Registration Date

July 13, 2021

First Use Anywhere

January 1, 2019

First Use in Commerce

January 1, 2019

Published for Opposition

April 27, 2021

Goods & Services

Downloadable mobile applications that use artificial intelligence to automate the monitoring of individuals with intellectual and developmental disabilities at home in the field of healthcare; downloadable mobile application in the field of healthcare for automated monitoring of patient medication, health emergencies and reminders, environmental data, home security and monitoring for use by families and provider agencies supporting those with intellectual and developmental disabilities; Downloadable computer software for automated monitoring of patient medication, health emergencies and reminders, environmental data, home security and monitoring for use by families and provider agencies supporting those with intellectual and developmental disabilities; Downloadable computer software that simplifies voice and video communications between provider agencies and the individuals with intellectual and developmental disabilities that they serve in the field of healthcare. None of the foregoing goods are for the medical diagnosis, management, and monitoring of certain conditions, namely in the nature of heart and cardio-vascular related conditions, lung related conditions, mental health conditions, medical conditions relating to speech and voice, and COVID 19 through products that monitor the human voice, speech, and breathing

Research and development of assistive technology in the field of healthcare for use by organizations supporting those with intellectual and developmental disabilities; development of computer software designed for the automated monitoring of patient medication, health emergencies and reminders, environmental data, home security and monitoring for use by families and provider agencies supporting those with intellectual and developmental disabilities; Technical support services, namely, remote troubleshooting in the nature of diagnosing computer hardware and software problems administration and management of in-house and hosted datacenter devices, databases and software applications; development of computer platforms; Platform as a service (PAAS) featuring computer software platforms for increasing the independence of seniors or persons with developmental disabilities by providing support remotely in real time using technology, video and voice communication between parties, activity and medication reminders, and information gathered through a variety of devices to provide both active and passive notifications to ensure the short-term and long-term safety of those being supported; Providing online, non-downloadable computer software for automated monitoring of patient medication, health emergencies and reminders, environmental data, home security and monitoring for use by families and provider agencies supporting those with intellectual and developmental disabilities; Providing online, non-downloadable computer software that simplifies voice and video communications between provider agencies and individuals with intellectual and developmental disabilities that they serve in the field of healthcare. None of the foregoing services are for the medical diagnosis, management, and monitoring of certain conditions, namely in the nature of heart and cardio-vascular related conditions, lung related conditions, mental health conditions, medical conditions relating to speech and voice, and COVID 19 through products that monitor the human voice, speech, and breathing

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 22, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 22, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 22, 2025 REAP
REGISTERED-PRINCIPAL REGISTER
Jul 13, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 27, 2021 NPUB
PUBLISHED FOR OPPOSITION
Apr 27, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 7, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 24, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 18, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 17, 2021 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 17, 2021 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 28, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 28, 2021 GNSL
SUSPENSION LETTER WRITTEN
Jan 28, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 16, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 15, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 15, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 15, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jul 15, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jul 15, 2020 CNRT
ASSIGNED TO EXAMINER
Jul 9, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 27, 2020 NWOS
NEW APPLICATION ENTERED
Apr 21, 2020 NWAP